#United States #New York #Investor Relations #Tender Pricing #Mount Sinai Hospital

Mount Sinai Hospital: Tender Pricing Information Announced

On July 16, 2025, Mount Sinai Hospital (MSH) officially disclosed essential details regarding its tender pricing offers. This announcement comes following the Offer to Purchase initiated on July 1, 2025, inviting bondholders to tender their Target Bonds for cash. These bonds will be acquired based on a defined pricing strategy, ensuring investors are equipped with the necessary knowledge to participate effectively.

Offer Details and Key Dates

The tender pricing details and critical timelines were laid out, including the Early Tender Deadline, which was set for 5:00 p.m. New York City time, on July 15, 2025. The Expiration Date is scheduled for 5:00 p.m. on July 30, 2025, with the Settlement Date expected on August 4, 2025. Investors need to be aware that all capitalized terms used in the announcement are as defined in the Offer to Purchase documentation.

The announcement also stated that the tender offers are contingent upon meeting the Aggregate Minimum Tender Amount and applicable Tender Caps. As confirmed by MSH, by the Early Tender Date, the total principal amount of tendered Target Bonds exceeded the Aggregate Minimum Tender Amount, which means that, barring any complications, all submitted Target Bonds are likely to be accepted for purchase without any proration.

Analysis of Pricing and Bonds

The pricing for the tendered Target Bonds is based on a fixed spread over the relevant Reference Yield, linked to the yield of associated Reference U.S. Treasury Securities. Key metrics, such as the interest rate and the determined Reference Yield for each bond, are crucial for investors as they inform their decisions. For example, a bond set to mature in 2035 with a principal amount of $75 million had a purchase yield determined at 6.411%, while another maturing in 2048 with a total of $307 million showed a purchase yield of 6.852%.

Investors will receive payment based on the Total Consideration or Late Tender Consideration, depending on their timing of bond submission. Specifically, MSH anticipates that payment will be made on the Settlement Date, encompassing accrued interest on the Target Bonds validly tendered.

Additional Information for Investors

For any inquiries, Jefferies LLC serves as the Dealer Manager for the tender offer, and they can be reached for clarifications about the offer at their New York office. Furthermore, Globic Advisors Inc. acts as the information and tender agent and is available for guidance regarding the tender process.

Holders are strongly encouraged to consult the full Offer to Purchase documentation for comprehensive information regarding the bond tender process. This documentation includes essential details on terms, conditions, and any updates or changes to the tender offer framework, making it an invaluable resource for investors.

Forward-Looking Statements and Considerations

In line with regulations, MSH included cautionary statements regarding forward-looking information about its operations, projecting potential outcomes based on current trends and data. The Management at MSH acknowledges inherent risks and uncertainties within the financial landscape that might affect forecasted results. They place an emphasis on continuous assessment of these aspects, reassuring investors that updates will follow when necessary and permissible by law.

Conclusion

This announcement by Mount Sinai Hospital is pivotal as it provides clear and necessary information for involved investors, shaping their investment strategies and decision-making with respect to the tender offers of their Target Bonds. Understanding the outlined tender process and actively engaging in these opportunities could provide financial benefits and insights into MSH’s ongoing investment initiatives.